Abstract
No public abstract is available from the verified source records.
Edoardo G. Giannini
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
unpaywall
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
EASL Clinical Practice Guidelines on Hepatitis Delta Virus
10.1016/j.jhep.2023.05.001 · 2023
Origin, HDV Genotype and Persistent Viremia Determine Outcome and Treatment Response in Patients With Chronic Hepatitis Delta
10.1016/j.jhep.2020.06.038 · 2020
Effect of Variants in LGP2 on MDA5‐Mediated Activation of Interferon Response and Suppression of Hepatitis D Virus Replication
10.1016/j.jhep.2022.08.041 · 2023
10.1111/apt.70971
10.1111/apt.70971
Hepatitis D Virus‐Induced Interferon Response and Administered Interferons Control Cell Division‐Mediated Virus Spread
10.1016/j.jhep.2022.05.023 · 2022
Hepatitis Delta Genotype 5 Is Associated With Favourable Disease Outcome and Better Response to Treatment Compared to Genotype 1
10.1016/j.jhep.2019.12.028 · 2020
Bulevirtide Combined With Pegylated Interferon for Chronic Hepatitis D
10.1056/nejmoa2314134 · 2024
Characteristics and Outcome of Anti‐Hepatitis D Virus Positive Patients With Hepatocellular Carcinoma
10.1111/liv.15855 · 2024
No additional external references are available.